Mendelson Daniel Newman — SEC insider filings
SEC reporting owner CIK 1327897. 34 insider filings on record with FilingPulse; latest filed 2026-11-09.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2020-11-03 to 2026-11-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 25 legs across 25 filings — 75,504 shares, $441,769 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 5,000 shares @ $6.40 ($32,000) in CHAMPIONS ONCOLOGY, INC., filed 2023-10-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | Director | 34 | 25 legs · 75,504 sh · $441,769 | — | 15 |
Insider filings — Mendelson Daniel Newman
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-09 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 20,291 (derivative) @ $4.76 | EDGAR |
| 2025-11-07 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 13,790 (derivative) @ $6.80 | EDGAR |
| 2024-11-18 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 21,590 (derivative) @ $4.64 | EDGAR |
| 2024-01-16 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 1,000 @ $6.50 | EDGAR |
| 2024-01-12 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 2,000 @ $6.27 | EDGAR |
| 2024-01-11 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 2,944 @ $6.31 | EDGAR |
| 2024-01-10 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 3,000 @ $6.25 | EDGAR |
| 2024-01-09 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 1,000 @ $6.15 | EDGAR |
| 2024-01-08 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 3,000 @ $6.12 | EDGAR |
| 2024-01-08 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 2,000 @ $6.09 | EDGAR |
| 2024-01-04 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 500 @ $5.83 | EDGAR |
| 2023-12-26 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 2,500 @ $4.92 | EDGAR |
| 2023-12-21 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 2,100 @ $4.82 | EDGAR |
| 2023-12-20 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 5,000 @ $4.75 | EDGAR |
| 2023-11-07 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 26,220 (derivative) @ $5.51 | EDGAR |
| 2023-10-16 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 1,500 @ $5.95 | EDGAR |
| 2023-10-16 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 5,000 @ $6.22 | EDGAR |
| 2023-10-16 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 4,000 @ $6.16 | EDGAR |
| 2023-10-13 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 5,000 @ $6.40 | EDGAR |
| 2023-10-11 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 1,100 @ $6.41 | EDGAR |
| 2023-10-10 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 1,530 @ $6.48 | EDGAR |
| 2023-10-06 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 2,000 @ $6.47 | EDGAR |
| 2023-10-04 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 5,000 @ $6.40 | EDGAR |
| 2023-10-04 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 2,500 @ $6.30 | EDGAR |
| 2023-09-27 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 5,000 @ $5.65 | EDGAR |
| 2023-09-25 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 3,812 @ $5.50 | EDGAR |
| 2023-09-25 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 5,000 @ $5.51 | EDGAR |
| 2023-09-25 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 4,018 @ $5.51 | EDGAR |
| 2023-09-25 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Purchase (P): 5,000 @ $5.28 | EDGAR |
| 2023-08-17 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 19,430 (derivative) @ $7 | EDGAR |
| 2021-11-09 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 13,614 (derivative) @ $10.10 | EDGAR |
| 2020-12-10 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 10,000 (derivative) @ $11.96 | EDGAR |
| 2020-11-03 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 34,375 @ $5.76 · Option exercise (M): 34,375 (derivative) @ $5.76 | EDGAR |
| 2020-11-03 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 10,000 @ $5.46 · Option exercise (M): 10,000 @ $1.59 · Option exercise (M): 10,000 @ $3.21 · Option exercise (M): 10,000 (derivative) @ $5.46 · Option exercise (M): 10,000 (derivative) @ $1.59 · Option exercise (M): 10,000 (derivative) @ $3.21 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1327897 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs